Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Background: Most travelers experience Jet Lag Disorder (JLD) symptoms due to misalignment of their circadian rhythms with respect to the new time zone. We assessed the efficacy and safety of tasimelteon (HETLIOZ®) in healthy participants using a laboratory model of JLD induced by an 8-h phase advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Polymeropoulos, Christos M., Mohrman, Michael A., Keefe, Madison S., Brzezynski, Jennifer L., Wang, Jingyuan, Prokosch, Lydia S., Polymeropoulos, Vasilios M., Xiao, Changfu, Birznieks, Gunther, Polymeropoulos, Mihael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381312/
https://www.ncbi.nlm.nih.gov/pubmed/32754110
http://dx.doi.org/10.3389/fneur.2020.00611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381312/
https://www.ncbi.nlm.nih.gov/pubmed/32754110
http://dx.doi.org/10.3389/fneur.2020.00611

Ejemplares similares